Essential Steps to Achieving Quality and Compliance
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationManufacturers can request advice on their medical device clinical development programme
Guidance for Institutions and IRBs OHRP's and FDA's guidance documents, including this guidance, do not establish legally enforceable responsibilities. Instead, guidance describes OHRP's and FDA's current thinking on a topic and should be viewed only as recommendations, unless specific regulatory or statutory requirements are cited.
This guidance clarifies the expectations on the application of the EU guidance on good pharmacovigilance practices (GVP) - guidance notes updated.
Link to Expression of Interest form added 10th Feb. 2025
Confirmation of when it is expected to come into force.
Released 3rd Feb 2025
Our current strategy was written to last three years, and now we’re planning a new strategy, starting in 2025, which will set out what we are going to do to deliver our mission over the next three years.
Blog post - how regulators can support growth which helps everyone
New guidance on product marking, including the continued recognition of certain EU requirements, such as CE marking, for specific product sectors.
New issue released.